Skip to main navigation
  • About
    • Who We Are
    • Core Values
    • Leadership
    • Partners
    • Intellia’s Journey
  • Our Science
    • What is CRISPR?
    • CRISPR Videos
    • Full-Spectrum Approach
    • Scientific Publications & Presentations
    • Glossary
  • Programs & Pipelines
    • Pipeline
    • Clinical Trials
  • Patient Stories
    • Patient Stories
    • Disease Focus
      • Overview
      • Transthyretin Amyloidosis
      • Hereditary Angioedema
      • Alpha-1 Antitrypsin Deficiency
      • Hodgkin Lymphoma
  • Investors & Media
    • Overview
    • Press Releases
    • Scientific Publications & Presentations
    • Corporate Deck
    • Events & Presentations
    • Press Kit
    • Corporate Governance
    • Financial Info
    • Stock Info
    • Analyst Coverage
    • Investor Resources
  • Careers
    • Life @ Intellia
    • Join Us
  • Full-Spectrum Blog
  • Contact
logo
  • Full-Spectrum Blog
  • Contact
  • About
    • Who We Are
    • Core Values
    • Leadership
    • Partners
    • Intellia’s Journey
  • Our Science
    • What is CRISPR?
    • CRISPR Videos
    • Full-Spectrum Approach
    • Scientific Publications &
      Presentations
    • Glossary
  • Programs & Pipelines
    • Pipeline
    • Clinical Trials
  • Patient Focus
    • Patient Stories
    • Disease Focus
  • Investors & Media
    • Overview
    • Press Releases
    • Scientific Publications &
      Presentations
    • Corporate Deck
    • Events &
      Presentations
    • Press Kit
    • Corporate Governance
    • Financial Info
    • Stock Info
    • Analyst Coverage
    • Investor Resources
  • Careers
    • Life @ Intellia
    • Join Us
Investors & Media

Events & Presentations

Investor Relations

  • Overview
  • Press Releases
  • Scientific Publications & Presentations
  • Corporate Deck
  • Events & Presentations
  • Press Kit
  • Corporate Governance
  • Financial Info
  • Stock Info
  • Analyst Coverage
  • Investor Resources

Events and Presentations

  • Upcoming Events
  • Past Events
  • Presentations
  • ESG Report
All Past Events
2023
2022
Mar 14, 2023 2:05 PM EDT
Barclays Global Healthcare Conference

Location:

Miami, FL
Click Here for Webcast
Mar 6, 2023 2:10 PM EST
Cowen 43rd Annual Health Care Conference

Location:

Boston, MA
Click Here for Webcast
Feb 23, 2023 8:00 AM EST
Intellia Therapeutics Fourth Quarter and Full Year 2022 Earnings Conference Call
US dial-in: 1-833-316-0545
International dial-in: 1-412-317-5726
All participants should ask to be connected to the Intellia Therapeutics conference call.
Click Here for Webcast
Feb 16, 2023 3:00 PM EST
SVB Securities Global Biopharma Conference

Location:

Virtual
Click Here for Webcast
Nov 29, 2022 2:00 PM EST
Piper Sandler 34th Annual Healthcare Conference

Location:

New York, NY
Listen to webcast
Nov 14, 2022 8:00 AM EST
Intellia Therapeutics Call to Discuss Interim Clinical Data of NTLA-2002
Click Here for Webcast

Supporting Materials

NTLA-2002 Interim Clinical Data Update – November 14, 2022 1.7 MB
Nov 3, 2022 8:00 AM EDT
Intellia Therapeutics Third Quarter 2022 Earnings Conference Call
US dial-in: 1-833-316-0545
International dial-in: 1-412-317-5726
All participants should ask to be connected to the Intellia Therapeutics conference call.
Click Here for Webcast
Oct 3, 2022 8:30 AM EDT
Chardan’s 6th Annual Genetic Medicines Conference

Location:

New York, NY
Click Here for Webcast
Sep 29, 2022 7:45 AM EDT
Guggenheim Nantucket Therapeutics Conference

Location:

Nantucket, Massachusetts
Click Here for Webcast
Sep 16, 2022 8:00 AM EDT
Intellia Therapeutics Call to Discuss Interim Clinical Data of NTLA-2002 and NTLA-2001
Click Here for Webcast

Supporting Materials

NTLA-2001 and NTLA-2002 Interim Clinical Data Update – September 16, 2022 2.8 MB
Sep 16, 2022 10:55 AM CEST
2022 Bradykinin Symposium

Location:

Berlin, Germany

Supporting Materials

In vivo CRISPR/Cas9 editing of KLHB1 in patients with HAE – September 16, 2022 1 MB
Aug 4, 2022 8:00 AM EDT
Intellia Therapeutics Second Quarter 2022 Earnings Conference Call
US dial-in: 1-833-316-0545
International dial-in: 1-412-317-5726
All participants should ask to be connected to the Intellia Therapeutics conference call.
Click Here for Webcast
Jun 24, 2022 8:00 AM EDT
Intellia Therapeutics Call to Discuss Interim Clinical Data from NTLA-2001 Phase 1 Study
Click Here for Webcast

Supporting Materials

NTLA-2001 for ATTR Amyloidosis: Interim Clinical Results from Ongoing Phase 1 Trial – June 24, 2022 1 MB
Jun 14, 2022 9:00 AM EDT
Intellia Therapeutics 2022 Annual Meeting of Shareholders

Location:

Virtual meeting via internet
Jun 9, 2022 8:30 AM EDT
Jefferies Healthcare Conference

Location:

New York, New York
Click Here for Webcast
May 5, 2022 8:00 AM EDT
Intellia Therapeutics First Quarter 2022 Earnings Conference Call

US dial-in: 1-833-316-0545
International dial-in: 1-412-317-5726
All participants should ask to be connected to the Intellia Therapeutics conference call.

Click Here for Webcast
Contact IR Contact IR
Email Alerts
RSS Feeds
RSS Feeds
Print Page

Footer Links

  • Cookie Policy
  • Terms of Use
  • Privacy Policy

© Intellia Therapeutics, Inc. 2023

Intellia Therapeutics and the Intellia Therapeutics logo are registered trademarks with the U.S. Patent & Trademark Office.